Impact of Regorafenib on Endothelial Transdifferentiation of Glioblastoma Stem-like Cells.

Deshors, Pauline; Arnauduc, Florent; Boëlle, Betty; Cohen-Jonathan Moyal, Elizabeth; Courtade-Saïdi, Monique; Evrard, Solène M

Deshors, Pauline; Arnauduc, Florent; Boëlle, Betty; Cohen-Jonathan Moyal, Elizabeth; Courtade-Saïdi, Monique; Evrard, Solène M.

Afiliación

Deshors P; Institut Claudius Regaud, IUCT Oncopole, 31059 Toulouse, France.
Arnauduc F; Faculty of Medicine, Paul Sabatier University, Toulouse-3, 31062 Toulouse, France.
Boëlle B; INSERM UMR 1037, Centre for Cancer Research of Toulouse, 31100 Toulouse, France.
Cohen-Jonathan Moyal E; Institut Claudius Regaud, IUCT Oncopole, 31059 Toulouse, France.
Courtade-Saïdi M; Institut Claudius Regaud, IUCT Oncopole, 31059 Toulouse, France.
Evrard SM; Faculty of Medicine, Paul Sabatier University, Toulouse-3, 31062 Toulouse, France.

Cancers (Basel) ; 14(6)2022 Mar 18.

Article en En | MEDLINE | ID: mdl-35326702

Palabras clave

glioblastoma; glioblastoma stem-like cells; ionising radiation; regorafenib; transdifferentiation; tumour-derived endothelial cells

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Francia